V025-3529 Screening compound: N-(1-{[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)hexanamide

V025-3529 Screening compound: N-(1-{[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)hexanamide
V025-3529 Screening compound: N-(1-{[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)hexanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-3529
N-(1-{[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)hexanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-3529

Molecular Formula

C23H25ClN4O2S (C23 H25 ClN4 O2 S)

Compound Name

N-(1-{[5-(3-chlorophenyl)-1,3,4-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)hexanamide

IUPAC name

N-(1-{[5-(3-chlorophenyl)-134-thiadiazol-2-yl]carbamoyl}-2-phenylethyl)hexanamide

SMILES

CCCCCC(NC(Cc1ccccc1)C(Nc1nnc(-c2cccc(Cl)c2)s1)=O)=O

InChI

InChI=1S/C23H25ClN4O2S/c1-2-3-5-13-20(29)25-19(14-16-9-6-4-7-10-16)21(30)26-23-28-27-22(31-23)17-11-8-12-18(24)15-17/h4,6-12,15,19H,2-3,5,13-14H2,1H3,(H,25,29)(H,26,28,30)/t19-/m0/s1

InChI Key

RWIWTLXHDXHTQT-IBGZPJMESA-N

MDL Number (MFCD)

MFCD19723300

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

457

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.837

Distribution Coefficient, logD

5.836

Water Solubility, LogSw

-5.74

Polar Surface Area

70.705

Acid Dissociation Constant (pKa)

10.06

Base Dissociation Constant (pKb)

-2.73

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

30.40

V025-3529 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with V025-3529 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-3529?
Check Price and Availability of V025-3529, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-3529 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-3529
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-3529
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-3529 available by request